MENEGATTI, Enea
 Distribuzione geografica
Continente #
NA - Nord America 8.868
AS - Asia 4.291
EU - Europa 2.637
SA - Sud America 779
AF - Africa 65
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.654
Nazione #
US - Stati Uniti d'America 8.739
SG - Singapore 1.696
CN - Cina 1.328
UA - Ucraina 668
BR - Brasile 653
DE - Germania 432
HK - Hong Kong 431
IT - Italia 430
GB - Regno Unito 310
TR - Turchia 309
VN - Vietnam 205
SE - Svezia 184
FI - Finlandia 170
RU - Federazione Russa 131
IN - India 90
FR - Francia 87
MX - Messico 67
AR - Argentina 51
CA - Canada 47
PL - Polonia 44
JP - Giappone 32
AT - Austria 31
NL - Olanda 30
ZA - Sudafrica 29
BD - Bangladesh 27
IQ - Iraq 26
ID - Indonesia 24
EC - Ecuador 23
LT - Lituania 19
ES - Italia 18
RO - Romania 18
BE - Belgio 17
PK - Pakistan 16
CO - Colombia 14
KR - Corea 12
TH - Thailandia 12
JO - Giordania 11
IL - Israele 10
PH - Filippine 10
CL - Cile 9
SA - Arabia Saudita 9
CH - Svizzera 8
CZ - Repubblica Ceca 8
IR - Iran 8
PE - Perù 8
PY - Paraguay 8
BF - Burkina Faso 6
DZ - Algeria 6
GR - Grecia 6
MA - Marocco 6
MY - Malesia 6
UY - Uruguay 6
AU - Australia 5
EG - Egitto 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
PA - Panama 4
VE - Venezuela 4
BO - Bolivia 3
GT - Guatemala 3
HU - Ungheria 3
KZ - Kazakistan 3
MD - Moldavia 3
NP - Nepal 3
UZ - Uzbekistan 3
BH - Bahrain 2
BY - Bielorussia 2
ET - Etiopia 2
KE - Kenya 2
LV - Lettonia 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 16.652
Città #
Woodbridge 979
Singapore 911
Fairfield 782
Houston 722
Jacksonville 721
Ashburn 694
Chandler 565
Santa Clara 526
Ann Arbor 448
Hong Kong 420
Beijing 386
Seattle 298
Wilmington 284
Cambridge 252
Izmir 204
Nanjing 203
Princeton 141
New York 122
Boardman 112
Los Angeles 108
Dallas 103
Ho Chi Minh City 89
San Diego 82
Munich 68
Shenyang 63
São Paulo 63
Milan 55
Nanchang 55
Mexico City 51
Shanghai 51
Hefei 49
Hanoi 39
Hebei 39
Changsha 37
Tianjin 36
Jiaxing 33
Warsaw 33
Dearborn 32
Brooklyn 31
Rio de Janeiro 30
Chicago 29
Jinan 29
Falkenstein 28
Buffalo 27
Tokyo 27
Norwalk 26
Ferrara 25
San Mateo 25
London 24
Mountain View 23
Denver 22
Vienna 22
Belo Horizonte 21
Stockholm 21
Helsinki 20
Moscow 20
Redwood City 20
Rome 20
Falls Church 19
Kunming 19
Ningbo 19
Montreal 18
Poplar 18
Brussels 17
Johannesburg 17
Turku 17
Auburn Hills 16
Chennai 16
Frankfurt am Main 16
Ankara 14
Atlanta 13
Brasília 12
Manchester 12
San Francisco 12
Verona 12
Zhengzhou 12
Baghdad 11
Boston 11
Indiana 11
Mumbai 11
Orange 11
Philadelphia 11
Amman 10
Amsterdam 10
Guangzhou 10
Hangzhou 10
Lanzhou 10
Bangkok 9
Bremen 9
Curitiba 9
Naples 9
Porto Alegre 9
Çankaya 9
Augusta 8
Bexley 8
Dhaka 8
Guayaquil 8
Redmond 8
Salvador 8
Taizhou 8
Totale 10.851
Nome #
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 335
Skin care: The innovative nanotechnology to improve the performance of delivery systems 225
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 204
Amphiphilic association systems for amphotericin B delivery 198
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin 193
Respiratory Drug Delivery 191
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 187
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 183
Amphiphilic association systems for Amphotericin B delivery 182
Clotrimazole Nanoparticle gel for mucosal administration. 182
A novel multicompartimental system based on aminated poly(vinyl alcohol) microspheres/succinoylated pullulan microspheres for oral delivery of anionic drugs 181
Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA 178
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 176
Design and characterization of fenretinide containing organogels 176
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 175
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 174
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 174
Cationic lipid nanosystems as carriers for nucleic acids 167
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 162
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 161
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 160
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 159
Characterization of low -molecular-mass trypsin isoinhibitors from oil-rape (Brassica napus var. oleifera) seed 159
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 159
Microparticles as delivery systems for local delivery to the oral cavity. 158
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 158
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 156
Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study 156
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 155
Influence of formulation and process parameters on pellet production by powder layering technique 154
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 153
Eudragit® microparticles for the release of budesonide: A comparative study 153
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 152
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 152
Characterization of five new low-molecular-mass trypsin inhibitors from white mustard (Sinapis alba L.)seed 152
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 151
Budesonide microparticles for the treatment of Crohn's disease 150
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 149
Active substance controlled release device for sanitization of spaces susceptible of containing degenerative organic material 147
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 147
Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate 146
Cross-enzyme inhibition by gabexate mesylate: Formulation and reactivity study 144
Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors 144
Lipid-based supramolecular systems for topical application: A preformulatory study 144
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 142
Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug 141
Spray dried Eudragit microparticles as encapsulation devices for vitamin C 139
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 139
Preparation and characterization of cationic microspheres for gene delivery 139
In vitro antiproliferative activity of isothiocyanates and nitriles generated by myrosinase-mediated hydrolysis of glucosinolates from seeds of cruciferous vegetables 138
Alginate and cell combination product for wound healing 138
Poly[(N-isopropylacrylamide-co-acrylamide-co-(hydroxyethylmethacrylate)]thermoresponsive microspheres: an accurate method based on solute exclusion technique to determine the volume phase transition temperature 138
Dextran cross-linked gelatin microspheres as a drug delivery system 138
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 137
Hyaluronan-based microspheres as tools for drug delivery: a comparative study 136
Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs 136
Eudragit® /Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 135
Properties and applications of liposomes in cosmetics 134
Liposomes- and ethosomes-associated distamycins: a comparative study 134
Nanosystems for skin hydration: a comparative study 134
Colloidal dispersions for the delivery of acyclovir: A comparative study 133
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies 132
Preparation and characterisation of thermoresponsive poly [(N-isopropylacrylamide-co-acrylamide-co(hydroxyethyl acrylate)] microspheres as a matrix for the pulsed release of drugs 132
Combination of alginate and cells for skin regeneration 131
Development of polymethacrylic/poloxamer microparticles for topical administration of biotech drugs 129
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 125
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 125
Materie Prime: Eccipienti 124
Nasal administration and brain targeting of an antiischemic agent 121
Production of pellet by powder layering technique: coating with acrylic polymers for enteric drug release 121
Production and characterization of cubosome: a new tool for percutaneous administration of lipophilic drugs 121
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 117
Lecithin organogels as cosmetic formulations for methyl nicotinate 117
Eudragit®/Pluronic nanoparticles for the administration of peptides and proteins 116
Ethosomes for the delivery of anti-HSV-1 molecules: preparation, characterization and in vitro activity. 114
Preparation and characterization of collagen sponges for dermo-cosmetic applications 114
null 113
DNA binding activity and inhibition of DNA-protein interactions. Differential effects of tetra-p-amidino-phenoxyneopentane and its 2′-bromo derivative 112
Lipid-based dispersions for drug delivery 108
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 108
Spray-drying production of trypsin-containing microparticles 108
Innovative nanotechnology based systems for dermal application 104
Modulation of protease activity by NO-mediated S-nitrosylation. 103
Ethosomes for the delivery of anti-herpetic molecules 103
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 102
NEW DELIVERY SYSTEMS FOR RETINOIDS APPLICATION 101
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 101
Peptide-based molecules for the production of positive charged liposomes and micelles 100
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine 100
Liposomes and micellar solutions for the delivery of some benzoheterocyclic derivatives of distamycin A 97
Spray drying production of trypsin containing microparticles 97
Production and antiproliferative activity of liposomes containing the antitumour drug chromomycin A(3) 96
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 96
Oligonucleotide-carrying microspheres. Production, characterization and release characteristics 95
Enhancing ribavirin nose-to-brain delivery by powder formulation for veterinary CNS infections 95
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 95
Eudragit/Pluronic microparticles for topical administration of peptides and proteins 94
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 94
Semisolid formulations based on MAD or NLC for mucosal administration of Clotrimazole 94
Diffusion of preservatives from topical dosage forms: A comparative study 92
Totale 14.040
Categoria #
all - tutte 75.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.900
Totale 79.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021862 0 0 0 0 0 153 47 177 23 163 217 82
2021/20221.252 43 153 114 79 41 52 64 77 36 95 125 373
2022/20231.302 151 48 32 164 221 224 25 130 170 8 88 41
2023/2024623 76 83 24 10 43 114 29 40 8 30 36 130
2024/20252.656 74 41 183 68 385 282 88 152 465 264 391 263
2025/20263.861 698 375 662 1.113 891 122 0 0 0 0 0 0
Totale 16.742